SCOPUS 정보 검색 플랫폼

Volumn 79, Issue 5, 2012, Pages 460-463

Effectiveness of anakinra in the treatment of acute refractory arthritis induced by calcium pyrophosphate crystals (PPCa);Efficacité de l'anakinra dans le traitement de l'arthrite réfractaire aiguë induite par cristaux de PPCa

(5) Moltó, Anna a Ea, Hang Korng a,b,c Richette, Pascal a,b,c Bardin, Thomas a,b,c Lioté, Frédéric a,b,c

a AP HP ^* (France)

b UNIVERSITÉ PARIS DESCARTES (France)

c INSERM (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868227019 PISSN: 11698330 EISSN: None Source Type: Journal
DOI: 10.1016/j.rhum.2012.03.002 Document Type: Article

Times cited : (2)

References (14)

1
- 67650093602
- An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease
- P. Richette, T. Bardin, and M. Doherty An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease Rheumatology (Oxford) 48 2009 711 715
- (2009) Rheumatology (Oxford) , vol.48 , pp. 711-715
- Richette, P.¹ Bardin, T.² Doherty, M.³

2
- 32944468985
- Gout-associated uric acid crystals activate the NALP3 inflammasome
- DOI 10.1038/nature04516, PII N04516
- F. Martinon, V. Petrilli, and A. Mayor Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 440 2006 237 241 (Pubitemid 43372104)
- (2006) Nature , vol.440 , Issue.7081 , pp. 237-241
- Martinon, F.¹ Petrilli, V.² Mayor, A.³ Tardivel, A.⁴ Tschopp, J.⁵

3
- 67649798632
- Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure
- N. Announ, G. Palmer, and P.-A. Guerne Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure Joint Bone Spine 76 2009 424 426
- (2009) Joint Bone Spine , vol.76 , pp. 424-426
- Announ, N.¹ Palmer, G.² Guerne, P.-A.³

4
- 39749175570
- Successful treatment of resistant pseudogout with anakinra
- DOI 10.1002/art.23119
- D. McGonagle, A.L. Tan, and J. Madden Successful treatment of resistant pseudogout with anakinra Arthritis Rheum 58 2008 631 633 (Pubitemid 351294902)
- (2008) Arthritis and Rheumatism , vol.58 , Issue.2 , pp. 631-633
- McGonagle, D.¹ Tan, A.L.² Madden, J.³ Emery, P.⁴ McDermott, M.F.⁵

5
- 78650224244
- Blocking interleukin-1beta in acute and chronic autoinflammatory diseases
- C.A. Dinarello Blocking interleukin-1beta in acute and chronic autoinflammatory diseases J Intern Med 269 2011 16 28
- (2011) J Intern Med , vol.269 , pp. 16-28
- Dinarello, C.A.¹

6
- 34047174085
- A pilot study of IL-1 inhibition by anakinra in acute gout
- A. So, T. De Smedt, and S. Revaz A pilot study of IL-1 inhibition by anakinra in acute gout Arthritis Res Ther 9 2007 R28
- (2007) Arthritis Res Ther , vol.9 , pp. 28
- So, A.¹ De Smedt, T.² Revaz, S.³

7
- 79952363638
- EULAR recommendations for calcium pyrophosphate deposition. Part I: Terminology and diagnosis
- W. Zhang, M. Doherty, and T. Bardin EULAR recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis Ann Rheum Dis 70 2011 563 570
- (2011) Ann Rheum Dis , vol.70 , pp. 563-570
- Zhang, W.¹ Doherty, M.² Bardin, T.³

8
- 79952359415
- EULAR recommendations for calcium pyrophosphate deposition. Part II: Management
- W. Zhang, M. Doherty, and E. Pascual EULAR recommendations for calcium pyrophosphate deposition. Part II: management Ann Rheum Dis 70 2011 571 575
- (2011) Ann Rheum Dis , vol.70 , pp. 571-575
- Zhang, W.¹ Doherty, M.² Pascual, E.³

9
- 70349402166
- The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: Results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
- R. Terkeltaub, J.S. Sundy, and H.R. Schumacher The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study Ann Rheum Dis 68 2009 1613 1617
- (2009) Ann Rheum Dis , vol.68 , pp. 1613-1617
- Terkeltaub, R.¹ Sundy, J.S.² Schumacher, H.R.³

10
- 77949571201
- Anti-IL-1 molecules: New comers and new indications
- A. Molto, and A. Olivé Anti-IL-1 molecules: new comers and new indications Joint Bone Spine 77 2010 102 107
- (2010) Joint Bone Spine , vol.77 , pp. 102-107
- Molto, A.¹ Olivé, A.²

11
- 78649445097
- Anakinra's efficacy is variable in refractory gout: Report of ten cases
- K. Chen, T. Fields, and C.A. Mancuso Anakinra's efficacy is variable in refractory gout: report of ten cases Semin Arthritis Rheum 40 2010 210 214
- (2010) Semin Arthritis Rheum , vol.40 , pp. 210-214
- Chen, K.¹ Fields, T.² Mancuso, C.A.³

12
- 77957688721
- Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study
- A. So, M. De Meulemeester, and A. Pikhlak Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study Arthritis Rheum 62 2010 3064 3076
- (2010) Arthritis Rheum , vol.62 , pp. 3064-3076
- So, A.¹ De Meulemeester, M.² Pikhlak, A.³

13
- 79957646006
- Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: Results of a double-blind, randomised study
- N. Schlesinger, E. Mysler, and H.Y. Lin Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study Ann Rheum Dis 70 2011 1264 1271
- (2011) Ann Rheum Dis , vol.70 , pp. 1264-1271
- Schlesinger, N.¹ Mysler, E.² Lin, H.Y.³

14
- 79959433500
- Minimally important differences of the gout impact scale in a randomized controlled trial
- D. Khanna, A.J. Sarkin, and P.P. Khanna Minimally important differences of the gout impact scale in a randomized controlled trial Rheumatology (Oxford) 50 2011 1331 1336
- (2011) Rheumatology (Oxford) , vol.50 , pp. 1331-1336
- Khanna, D.¹ Sarkin, A.J.² Khanna, P.P.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.